Literature DB >> 16142428

Do antimicrobial susceptibility patterns of colonic isolates of Bacteroides species change after antibiotic prophylaxis with cefoxitine during elective abdominal surgery?

Nurver Ulger Toprak1, Bahadir M Güllüoğlu, Ozlem Cakici, M Levhi Akin, Pakize Demirkalem, Tuncay Celenk, Güner Söyletir.   

Abstract

The objectives of the study were to investigate and compare the susceptibility profiles of preoperative and postoperative intestinal Bacteroides fragilis and Bacteroides thetaiotaomicron strains against antimicrobials to evaluate their resistance development patterns due to prophylactic antibiotic administration. Preoperative and postoperative stool samples were obtained from patients undergoing elective abdominal surgery with a "clean-contaminated" wound categorization. All patients received cefoxitin 2 g as prophylaxis. Isolates of Bacteroides species were identified. Susceptibility tests against ampicillin, piperacillin, cefoxitin, clindamycin, chloramphenicol, metronidazole, imipenem, and amoxicillin-clavulanate were performed. Stool samples were collected from 40 patients at two settings: before and after the operation. Most of the patients (53%) were operated on because of colorectal carcinoma and underwent surgery that included colectomy or anterior resection. Bacteroides fragilis and Bacteroides thetaiotaomicron were isolated in both samples obtained from 22 and 34 patients, respectively. In the present study 95% to 100%, 50% to 74%, 46% to 64%, and 18% to 35% of preoperatively isolated Bacteroides species were resistant to ampicillin, cefoxitin, clindamycin, and piperacillin, respectively. Although there were no statistically significant difference, postoperative strains were more resistant than preoperative isolates, and the resistance rates were found to be 95% to 100%, 55% to 82%, 46% to 86%, and 37% to 41%, respectively. Both Bacteroides species isolated from all specimens before and after the surgery were uniformly susceptible to amoxicillin-clavulanate, imipenem, metronidazole, and chloramphenicol.Our data revealed that Bacteroides strains revealed high resistance to ampicillin, cefoxitin, piperacillin, and clindamycin. Metronidazole, imipenem, and amoxicillin-clavulanate seem highly effective against both Bacteroides species. Cefoxitin prophylaxis did not significantly increase the resistance patterns against antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142428     DOI: 10.1007/s00268-005-7961-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  26 in total

1.  Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy.

Authors:  P Montravers; R Gauzit; C Muller; J P Marmuse; A Fichelle; J M Desmonts
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

2.  Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996.

Authors:  D R Snydman; N V Jacobus; L A McDermott; S Supran; G J Cuchural; S Finegold; L Harrell; D W Hecht; P Iannini; S Jenkins; C Pierson; J Rihs; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

Review 3.  Virulence factors in anaerobes.

Authors:  B I Duerden
Journal:  Clin Infect Dis       Date:  1994-05       Impact factor: 9.079

Review 4.  Resistance factors in anaerobic bacteria.

Authors:  F P Tally; M H Malamy
Journal:  Scand J Infect Dis Suppl       Date:  1986

Review 5.  Clindamycin, metronidazole, and chloramphenicol.

Authors:  M J Kasten
Journal:  Mayo Clin Proc       Date:  1999-08       Impact factor: 7.616

Review 6.  Antimicrobial resistance in anaerobes.

Authors:  B A Rasmussen; K Bush; F P Tally
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

7.  Anaerobic infections in the surgical patient: microbial etiology and therapy.

Authors:  Charles E Edmiston; Candace J Krepel; Gary R Seabrook; William G Jochimsen
Journal:  Clin Infect Dis       Date:  2002-09-01       Impact factor: 9.079

8.  Perioperative antibiotics in nonemergency bowel surgery: a quality improvement project.

Authors:  J A Schell; C G Bynum; G J Fortune; G R Laiben; Y J Chang; J A Pirner
Journal:  South Med J       Date:  1998-10       Impact factor: 0.954

Review 9.  Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America.

Authors:  E P Dellinger; P A Gross; T L Barrett; P J Krause; W J Martone; J E McGowan; R L Sweet; R P Wenzel
Journal:  Clin Infect Dis       Date:  1994-03       Impact factor: 9.079

10.  High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan.

Authors:  Lee-Jene Teng; Po-Ren Hsueh; Jui-Chang Tsai; Shwu-Jen Liaw; Shen-Wu Ho; Kwen-Tay Luh
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

View more
  4 in total

1.  Pancreaticoduodenectomy for periampullary malignancies: the effect of bile colonization on the postoperative outcome.

Authors:  Alberto M Isla; John Griniatsos; Ali Riaz; Evangelos Karvounis; Robin C N Williamson
Journal:  Langenbecks Arch Surg       Date:  2006-11-07       Impact factor: 3.445

Review 2.  Gastrointestinal surgery and the gut microbiome: a systematic literature review.

Authors:  Suzie Ferrie; Amy Webster; Betty Wu; Charis Tan; Sharon Carey
Journal:  Eur J Clin Nutr       Date:  2020-07-13       Impact factor: 4.016

Review 3.  [Perioperative antibiotic prophylaxis].

Authors:  F Reutter; D A Reuter; H Hilgarth; A M Heilek; M S Goepfert; M A Punke
Journal:  Anaesthesist       Date:  2014-01       Impact factor: 1.041

4.  Antimicrobial resistance and prevalence of resistance genes in intestinal Bacteroidales strains.

Authors:  Viviane Nakano; Amanda do Nascimento e Silva; Victor Rafael Castillo Merino; Hannah M Wexler; Mario Julio Avila-Campos
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.